Regulatory impact statements

To help ensure the business compliance cost implications of regulatory proposals are explicit and comprehensively considered in developing policy, all policy proposals submitted to Cabinet require a regulatory impact statement (RIS). This section contains the Ministry's latest statements.

Where the policy proposal includes any compliance cost implications for business, these are set out in a business compliance cost statement (BCCS) within the regulatory impact statement.

Ministers and/or Cabinet may wish to review and amend the RIS/BCCS to ensure that they fully reflect the government's position and are of a high standard. Accordingly, some changes to the RIS/BCCS make take place after Cabinet consideration of the Cabinet submission.

Regulatory impact statements
Publication date Topic
20 February 2024 Allowing sales of cold medicines containing pseudoephedrine
30 October 2023 Amending the Health Entitlement Card Regulations 1993 and the Social Security Regulations 2018 to enable implementation of Community Connect to reduce public transport fares for people on low-income
30 October 2023 October 2022 review of remaining COVID-19 measures under the new approach
30 October 2023 Proposed amendments to Self-Isolation Requirements Order 2022
30 October 2023 Public health measures under the COVID-19 Public Health Response Act 2020
30 October 2023 Regulatory amendments to improve the economic opportunities of the Medicinal Cannabis Scheme
30 October 2023 Review of Public Health Measures to support the future of the COVID-19 Protection Framework and moving to the new strategy
30 October 2023 Transforming Mental Health Law - Second Tranche of Policy Decisions
04 September 2023 Amendments to prescribing regulations for controlled drugs
30 August 2023 Smoked Tobacco Regulations
28 August 2023 Establishing new safe areas under the Contraception, Sterilisation, and Abortion Act 1977
24 August 2023 The regulation of rongoā and small-scale producers of natural health products under the Therapeutic Products Bill
11 May 2023 Stage 2 Cost Recovery Impact Statement: Approval to Amend the Radiation Safety Regulations 2016
30 November 2022 Regulatory Impact Statement: Pharmacy ownership and licensing
30 November 2022 Regulatory Impact Statement: Therapeutic and Natural Health Products Regulation – Supplementary Analysis 2022 No 1
30 November 2022 Therapeutic and Natural Health Products Regulation – Supplementary Analysis 2022 No 2
23 November 2022 Future of the COVID-19 Public Health Response Act 2020
03 August 2022 Cost Recovery Impact Statement Problem Gambling Levy 2022/23 to 2024/25
07 June 2022 Amending the Medicines Act 1981 to allow for off-label use of COVID-19 vaccinations
13 April 2022 Amendment of fees specified in the Medicines Regulations 1984
Back to top